Global Women Sexual Disorder Drugs Treating Market Growth 2026-2032
The global Women Sexual Disorder Drugs Treating market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Several drugs are utilized in treating various sexual disorders in women. For instance, hypoactive sexual desire disorder (HSDD) can be addressed with medications like flibanserin (Addyi) or bremelanotide (Vyleesi), which work to increase sexual desire.
United States market for Women Sexual Disorder Drugs Treating is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Women Sexual Disorder Drugs Treating is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Women Sexual Disorder Drugs Treating is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Women Sexual Disorder Drugs Treating players cover Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Women Sexual Disorder Drugs Treating Industry Forecast? looks at past sales and reviews total world Women Sexual Disorder Drugs Treating sales in 2025, providing a comprehensive analysis by region and market sector of projected Women Sexual Disorder Drugs Treating sales for 2026 through 2032. With Women Sexual Disorder Drugs Treating sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Women Sexual Disorder Drugs Treating industry.
This Insight Report provides a comprehensive analysis of the global Women Sexual Disorder Drugs Treating landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Women Sexual Disorder Drugs Treating portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Women Sexual Disorder Drugs Treating market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Women Sexual Disorder Drugs Treating and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Women Sexual Disorder Drugs Treating.
This report presents a comprehensive overview, market shares, and growth opportunities of Women Sexual Disorder Drugs Treating market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Women Sexual Disorder Drugs Treating market?
What factors are driving Women Sexual Disorder Drugs Treating market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Women Sexual Disorder Drugs Treating market opportunities vary by end market size?
How does Women Sexual Disorder Drugs Treating break out by Type, by Application?
Several drugs are utilized in treating various sexual disorders in women. For instance, hypoactive sexual desire disorder (HSDD) can be addressed with medications like flibanserin (Addyi) or bremelanotide (Vyleesi), which work to increase sexual desire.
United States market for Women Sexual Disorder Drugs Treating is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Women Sexual Disorder Drugs Treating is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Women Sexual Disorder Drugs Treating is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Women Sexual Disorder Drugs Treating players cover Pfizer, Teva Pharmaceuticals, Duchesnay, Sprout Pharmaceuticals, Cosette Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Women Sexual Disorder Drugs Treating Industry Forecast? looks at past sales and reviews total world Women Sexual Disorder Drugs Treating sales in 2025, providing a comprehensive analysis by region and market sector of projected Women Sexual Disorder Drugs Treating sales for 2026 through 2032. With Women Sexual Disorder Drugs Treating sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Women Sexual Disorder Drugs Treating industry.
This Insight Report provides a comprehensive analysis of the global Women Sexual Disorder Drugs Treating landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Women Sexual Disorder Drugs Treating portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Women Sexual Disorder Drugs Treating market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Women Sexual Disorder Drugs Treating and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Women Sexual Disorder Drugs Treating.
This report presents a comprehensive overview, market shares, and growth opportunities of Women Sexual Disorder Drugs Treating market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Estrogen Therapy
- Ospemifene
- Flibanserin
- Bremelanotide
- Others
- Hospital Pharmacies
- Private Clinics
- Retail Pharmacies
- E-Commerce (B2B)
- E-Commerce (B2C)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva Pharmaceuticals
- Duchesnay
- Sprout Pharmaceuticals
- Cosette Pharmaceuticals
- Lupin
What is the 10-year outlook for the global Women Sexual Disorder Drugs Treating market?
What factors are driving Women Sexual Disorder Drugs Treating market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Women Sexual Disorder Drugs Treating market opportunities vary by end market size?
How does Women Sexual Disorder Drugs Treating break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Women Sexual Disorder Drugs Treating Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Women Sexual Disorder Drugs Treating by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Women Sexual Disorder Drugs Treating by Country/Region, 2021, 2025 & 2032
2.2 Women Sexual Disorder Drugs Treating Segment by Type
2.2.1 Estrogen Therapy
2.2.2 Ospemifene
2.2.3 Flibanserin
2.2.4 Bremelanotide
2.2.5 Others
2.2.6 Women Sexual Disorder Drugs Treating Sales by Type
2.2.6.1 Global Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
2.2.6.2 Global Women Sexual Disorder Drugs Treating Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Women Sexual Disorder Drugs Treating Sale Price by Type (2021-2026)
2.3 Women Sexual Disorder Drugs Treating Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Private Clinics
2.3.3 Retail Pharmacies
2.3.4 E-Commerce (B2B)
2.3.5 E-Commerce (B2C)
2.3.6 Women Sexual Disorder Drugs Treating Sales by Application
2.3.6.1 Global Women Sexual Disorder Drugs Treating Sale Market Share by Application (2021-2026)
2.3.6.2 Global Women Sexual Disorder Drugs Treating Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Women Sexual Disorder Drugs Treating Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Women Sexual Disorder Drugs Treating Breakdown Data by Company
3.1.1 Global Women Sexual Disorder Drugs Treating Annual Sales by Company (2021-2026)
3.1.2 Global Women Sexual Disorder Drugs Treating Sales Market Share by Company (2021-2026)
3.2 Global Women Sexual Disorder Drugs Treating Annual Revenue by Company (2021-2026)
3.2.1 Global Women Sexual Disorder Drugs Treating Revenue by Company (2021-2026)
3.2.2 Global Women Sexual Disorder Drugs Treating Revenue Market Share by Company (2021-2026)
3.3 Global Women Sexual Disorder Drugs Treating Sale Price by Company
3.4 Key Manufacturers Women Sexual Disorder Drugs Treating Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Women Sexual Disorder Drugs Treating Product Location Distribution
3.4.2 Players Women Sexual Disorder Drugs Treating Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR WOMEN SEXUAL DISORDER DRUGS TREATING BY GEOGRAPHIC REGION
4.1 World Historic Women Sexual Disorder Drugs Treating Market Size by Geographic Region (2021-2026)
4.1.1 Global Women Sexual Disorder Drugs Treating Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Women Sexual Disorder Drugs Treating Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Women Sexual Disorder Drugs Treating Market Size by Country/Region (2021-2026)
4.2.1 Global Women Sexual Disorder Drugs Treating Annual Sales by Country/Region (2021-2026)
4.2.2 Global Women Sexual Disorder Drugs Treating Annual Revenue by Country/Region (2021-2026)
4.3 Americas Women Sexual Disorder Drugs Treating Sales Growth
4.4 APAC Women Sexual Disorder Drugs Treating Sales Growth
4.5 Europe Women Sexual Disorder Drugs Treating Sales Growth
4.6 Middle East & Africa Women Sexual Disorder Drugs Treating Sales Growth
5 AMERICAS
5.1 Americas Women Sexual Disorder Drugs Treating Sales by Country
5.1.1 Americas Women Sexual Disorder Drugs Treating Sales by Country (2021-2026)
5.1.2 Americas Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026)
5.2 Americas Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
5.3 Americas Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Women Sexual Disorder Drugs Treating Sales by Region
6.1.1 APAC Women Sexual Disorder Drugs Treating Sales by Region (2021-2026)
6.1.2 APAC Women Sexual Disorder Drugs Treating Revenue by Region (2021-2026)
6.2 APAC Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
6.3 APAC Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Women Sexual Disorder Drugs Treating by Country
7.1.1 Europe Women Sexual Disorder Drugs Treating Sales by Country (2021-2026)
7.1.2 Europe Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026)
7.2 Europe Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
7.3 Europe Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Women Sexual Disorder Drugs Treating by Country
8.1.1 Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Country (2021-2026)
8.1.2 Middle East & Africa Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026)
8.2 Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
8.3 Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Women Sexual Disorder Drugs Treating
10.3 Manufacturing Process Analysis of Women Sexual Disorder Drugs Treating
10.4 Industry Chain Structure of Women Sexual Disorder Drugs Treating
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Women Sexual Disorder Drugs Treating Distributors
11.3 Women Sexual Disorder Drugs Treating Customer
12 WORLD FORECAST REVIEW FOR WOMEN SEXUAL DISORDER DRUGS TREATING BY GEOGRAPHIC REGION
12.1 Global Women Sexual Disorder Drugs Treating Market Size Forecast by Region
12.1.1 Global Women Sexual Disorder Drugs Treating Forecast by Region (2027-2032)
12.1.2 Global Women Sexual Disorder Drugs Treating Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Women Sexual Disorder Drugs Treating Forecast by Type (2027-2032)
12.7 Global Women Sexual Disorder Drugs Treating Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.1.3 Pfizer Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Duchesnay
13.3.1 Duchesnay Company Information
13.3.2 Duchesnay Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.3.3 Duchesnay Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Duchesnay Main Business Overview
13.3.5 Duchesnay Latest Developments
13.4 Sprout Pharmaceuticals
13.4.1 Sprout Pharmaceuticals Company Information
13.4.2 Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.4.3 Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sprout Pharmaceuticals Main Business Overview
13.4.5 Sprout Pharmaceuticals Latest Developments
13.5 Cosette Pharmaceuticals
13.5.1 Cosette Pharmaceuticals Company Information
13.5.2 Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.5.3 Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cosette Pharmaceuticals Main Business Overview
13.5.5 Cosette Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.6.3 Lupin Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Women Sexual Disorder Drugs Treating Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Women Sexual Disorder Drugs Treating by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Women Sexual Disorder Drugs Treating by Country/Region, 2021, 2025 & 2032
2.2 Women Sexual Disorder Drugs Treating Segment by Type
2.2.1 Estrogen Therapy
2.2.2 Ospemifene
2.2.3 Flibanserin
2.2.4 Bremelanotide
2.2.5 Others
2.2.6 Women Sexual Disorder Drugs Treating Sales by Type
2.2.6.1 Global Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
2.2.6.2 Global Women Sexual Disorder Drugs Treating Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Women Sexual Disorder Drugs Treating Sale Price by Type (2021-2026)
2.3 Women Sexual Disorder Drugs Treating Segment by Application
2.3.1 Hospital Pharmacies
2.3.2 Private Clinics
2.3.3 Retail Pharmacies
2.3.4 E-Commerce (B2B)
2.3.5 E-Commerce (B2C)
2.3.6 Women Sexual Disorder Drugs Treating Sales by Application
2.3.6.1 Global Women Sexual Disorder Drugs Treating Sale Market Share by Application (2021-2026)
2.3.6.2 Global Women Sexual Disorder Drugs Treating Revenue and Market Share by Application (2021-2026)
2.3.6.3 Global Women Sexual Disorder Drugs Treating Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Women Sexual Disorder Drugs Treating Breakdown Data by Company
3.1.1 Global Women Sexual Disorder Drugs Treating Annual Sales by Company (2021-2026)
3.1.2 Global Women Sexual Disorder Drugs Treating Sales Market Share by Company (2021-2026)
3.2 Global Women Sexual Disorder Drugs Treating Annual Revenue by Company (2021-2026)
3.2.1 Global Women Sexual Disorder Drugs Treating Revenue by Company (2021-2026)
3.2.2 Global Women Sexual Disorder Drugs Treating Revenue Market Share by Company (2021-2026)
3.3 Global Women Sexual Disorder Drugs Treating Sale Price by Company
3.4 Key Manufacturers Women Sexual Disorder Drugs Treating Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Women Sexual Disorder Drugs Treating Product Location Distribution
3.4.2 Players Women Sexual Disorder Drugs Treating Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR WOMEN SEXUAL DISORDER DRUGS TREATING BY GEOGRAPHIC REGION
4.1 World Historic Women Sexual Disorder Drugs Treating Market Size by Geographic Region (2021-2026)
4.1.1 Global Women Sexual Disorder Drugs Treating Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Women Sexual Disorder Drugs Treating Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Women Sexual Disorder Drugs Treating Market Size by Country/Region (2021-2026)
4.2.1 Global Women Sexual Disorder Drugs Treating Annual Sales by Country/Region (2021-2026)
4.2.2 Global Women Sexual Disorder Drugs Treating Annual Revenue by Country/Region (2021-2026)
4.3 Americas Women Sexual Disorder Drugs Treating Sales Growth
4.4 APAC Women Sexual Disorder Drugs Treating Sales Growth
4.5 Europe Women Sexual Disorder Drugs Treating Sales Growth
4.6 Middle East & Africa Women Sexual Disorder Drugs Treating Sales Growth
5 AMERICAS
5.1 Americas Women Sexual Disorder Drugs Treating Sales by Country
5.1.1 Americas Women Sexual Disorder Drugs Treating Sales by Country (2021-2026)
5.1.2 Americas Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026)
5.2 Americas Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
5.3 Americas Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Women Sexual Disorder Drugs Treating Sales by Region
6.1.1 APAC Women Sexual Disorder Drugs Treating Sales by Region (2021-2026)
6.1.2 APAC Women Sexual Disorder Drugs Treating Revenue by Region (2021-2026)
6.2 APAC Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
6.3 APAC Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Women Sexual Disorder Drugs Treating by Country
7.1.1 Europe Women Sexual Disorder Drugs Treating Sales by Country (2021-2026)
7.1.2 Europe Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026)
7.2 Europe Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
7.3 Europe Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Women Sexual Disorder Drugs Treating by Country
8.1.1 Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Country (2021-2026)
8.1.2 Middle East & Africa Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026)
8.2 Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Type (2021-2026)
8.3 Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Women Sexual Disorder Drugs Treating
10.3 Manufacturing Process Analysis of Women Sexual Disorder Drugs Treating
10.4 Industry Chain Structure of Women Sexual Disorder Drugs Treating
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Women Sexual Disorder Drugs Treating Distributors
11.3 Women Sexual Disorder Drugs Treating Customer
12 WORLD FORECAST REVIEW FOR WOMEN SEXUAL DISORDER DRUGS TREATING BY GEOGRAPHIC REGION
12.1 Global Women Sexual Disorder Drugs Treating Market Size Forecast by Region
12.1.1 Global Women Sexual Disorder Drugs Treating Forecast by Region (2027-2032)
12.1.2 Global Women Sexual Disorder Drugs Treating Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Women Sexual Disorder Drugs Treating Forecast by Type (2027-2032)
12.7 Global Women Sexual Disorder Drugs Treating Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.1.3 Pfizer Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Duchesnay
13.3.1 Duchesnay Company Information
13.3.2 Duchesnay Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.3.3 Duchesnay Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Duchesnay Main Business Overview
13.3.5 Duchesnay Latest Developments
13.4 Sprout Pharmaceuticals
13.4.1 Sprout Pharmaceuticals Company Information
13.4.2 Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.4.3 Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sprout Pharmaceuticals Main Business Overview
13.4.5 Sprout Pharmaceuticals Latest Developments
13.5 Cosette Pharmaceuticals
13.5.1 Cosette Pharmaceuticals Company Information
13.5.2 Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.5.3 Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Cosette Pharmaceuticals Main Business Overview
13.5.5 Cosette Pharmaceuticals Latest Developments
13.6 Lupin
13.6.1 Lupin Company Information
13.6.2 Lupin Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
13.6.3 Lupin Women Sexual Disorder Drugs Treating Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lupin Main Business Overview
13.6.5 Lupin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Women Sexual Disorder Drugs Treating Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Women Sexual Disorder Drugs Treating Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Estrogen Therapy
Table 4. Major Players of Ospemifene
Table 5. Major Players of Flibanserin
Table 6. Major Players of Bremelanotide
Table 7. Major Players of Others
Table 8. Global Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 9. Global Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Table 10. Global Women Sexual Disorder Drugs Treating Revenue by Type (2021-2026) & ($ million)
Table 11. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Type (2021-2026)
Table 12. Global Women Sexual Disorder Drugs Treating Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Women Sexual Disorder Drugs Treating Sale by Application (2021-2026) & (K Units)
Table 14. Global Women Sexual Disorder Drugs Treating Sale Market Share by Application (2021-2026)
Table 15. Global Women Sexual Disorder Drugs Treating Revenue by Application (2021-2026) & ($ million)
Table 16. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Application (2021-2026)
Table 17. Global Women Sexual Disorder Drugs Treating Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Women Sexual Disorder Drugs Treating Sales by Company (2021-2026) & (K Units)
Table 19. Global Women Sexual Disorder Drugs Treating Sales Market Share by Company (2021-2026)
Table 20. Global Women Sexual Disorder Drugs Treating Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Company (2021-2026)
Table 22. Global Women Sexual Disorder Drugs Treating Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Women Sexual Disorder Drugs Treating Producing Area Distribution and Sales Area
Table 24. Players Women Sexual Disorder Drugs Treating Products Offered
Table 25. Women Sexual Disorder Drugs Treating Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Women Sexual Disorder Drugs Treating Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Women Sexual Disorder Drugs Treating Sales Market Share Geographic Region (2021-2026)
Table 30. Global Women Sexual Disorder Drugs Treating Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Women Sexual Disorder Drugs Treating Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Women Sexual Disorder Drugs Treating Sales Market Share by Country/Region (2021-2026)
Table 34. Global Women Sexual Disorder Drugs Treating Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Women Sexual Disorder Drugs Treating Sales by Country (2021-2026) & (K Units)
Table 37. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Country (2021-2026)
Table 38. Americas Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 40. Americas Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 41. APAC Women Sexual Disorder Drugs Treating Sales by Region (2021-2026) & (K Units)
Table 42. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Region (2021-2026)
Table 43. APAC Women Sexual Disorder Drugs Treating Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 45. APAC Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 46. Europe Women Sexual Disorder Drugs Treating Sales by Country (2021-2026) & (K Units)
Table 47. Europe Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 49. Europe Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Women Sexual Disorder Drugs Treating
Table 55. Key Market Challenges & Risks of Women Sexual Disorder Drugs Treating
Table 56. Key Industry Trends of Women Sexual Disorder Drugs Treating
Table 57. Women Sexual Disorder Drugs Treating Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Women Sexual Disorder Drugs Treating Distributors List
Table 60. Women Sexual Disorder Drugs Treating Customer List
Table 61. Global Women Sexual Disorder Drugs Treating Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Women Sexual Disorder Drugs Treating Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Women Sexual Disorder Drugs Treating Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Women Sexual Disorder Drugs Treating Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Women Sexual Disorder Drugs Treating Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Women Sexual Disorder Drugs Treating Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Women Sexual Disorder Drugs Treating Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Women Sexual Disorder Drugs Treating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Women Sexual Disorder Drugs Treating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Women Sexual Disorder Drugs Treating Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Women Sexual Disorder Drugs Treating Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Women Sexual Disorder Drugs Treating Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Women Sexual Disorder Drugs Treating Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 77. Pfizer Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Teva Pharmaceuticals Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 82. Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Teva Pharmaceuticals Main Business
Table 84. Teva Pharmaceuticals Latest Developments
Table 85. Duchesnay Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 86. Duchesnay Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 87. Duchesnay Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Duchesnay Main Business
Table 89. Duchesnay Latest Developments
Table 90. Sprout Pharmaceuticals Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 91. Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 92. Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Sprout Pharmaceuticals Main Business
Table 94. Sprout Pharmaceuticals Latest Developments
Table 95. Cosette Pharmaceuticals Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 96. Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 97. Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Cosette Pharmaceuticals Main Business
Table 99. Cosette Pharmaceuticals Latest Developments
Table 100. Lupin Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 101. Lupin Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 102. Lupin Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Lupin Main Business
Table 104. Lupin Latest Developments
Table 1. Women Sexual Disorder Drugs Treating Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Women Sexual Disorder Drugs Treating Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Estrogen Therapy
Table 4. Major Players of Ospemifene
Table 5. Major Players of Flibanserin
Table 6. Major Players of Bremelanotide
Table 7. Major Players of Others
Table 8. Global Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 9. Global Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Table 10. Global Women Sexual Disorder Drugs Treating Revenue by Type (2021-2026) & ($ million)
Table 11. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Type (2021-2026)
Table 12. Global Women Sexual Disorder Drugs Treating Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Women Sexual Disorder Drugs Treating Sale by Application (2021-2026) & (K Units)
Table 14. Global Women Sexual Disorder Drugs Treating Sale Market Share by Application (2021-2026)
Table 15. Global Women Sexual Disorder Drugs Treating Revenue by Application (2021-2026) & ($ million)
Table 16. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Application (2021-2026)
Table 17. Global Women Sexual Disorder Drugs Treating Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Women Sexual Disorder Drugs Treating Sales by Company (2021-2026) & (K Units)
Table 19. Global Women Sexual Disorder Drugs Treating Sales Market Share by Company (2021-2026)
Table 20. Global Women Sexual Disorder Drugs Treating Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Company (2021-2026)
Table 22. Global Women Sexual Disorder Drugs Treating Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Women Sexual Disorder Drugs Treating Producing Area Distribution and Sales Area
Table 24. Players Women Sexual Disorder Drugs Treating Products Offered
Table 25. Women Sexual Disorder Drugs Treating Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Women Sexual Disorder Drugs Treating Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Women Sexual Disorder Drugs Treating Sales Market Share Geographic Region (2021-2026)
Table 30. Global Women Sexual Disorder Drugs Treating Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Women Sexual Disorder Drugs Treating Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Women Sexual Disorder Drugs Treating Sales Market Share by Country/Region (2021-2026)
Table 34. Global Women Sexual Disorder Drugs Treating Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Women Sexual Disorder Drugs Treating Sales by Country (2021-2026) & (K Units)
Table 37. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Country (2021-2026)
Table 38. Americas Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 40. Americas Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 41. APAC Women Sexual Disorder Drugs Treating Sales by Region (2021-2026) & (K Units)
Table 42. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Region (2021-2026)
Table 43. APAC Women Sexual Disorder Drugs Treating Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 45. APAC Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 46. Europe Women Sexual Disorder Drugs Treating Sales by Country (2021-2026) & (K Units)
Table 47. Europe Women Sexual Disorder Drugs Treating Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 49. Europe Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Women Sexual Disorder Drugs Treating Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Women Sexual Disorder Drugs Treating
Table 55. Key Market Challenges & Risks of Women Sexual Disorder Drugs Treating
Table 56. Key Industry Trends of Women Sexual Disorder Drugs Treating
Table 57. Women Sexual Disorder Drugs Treating Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Women Sexual Disorder Drugs Treating Distributors List
Table 60. Women Sexual Disorder Drugs Treating Customer List
Table 61. Global Women Sexual Disorder Drugs Treating Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Women Sexual Disorder Drugs Treating Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Women Sexual Disorder Drugs Treating Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Women Sexual Disorder Drugs Treating Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Women Sexual Disorder Drugs Treating Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Women Sexual Disorder Drugs Treating Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Women Sexual Disorder Drugs Treating Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Women Sexual Disorder Drugs Treating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Women Sexual Disorder Drugs Treating Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Women Sexual Disorder Drugs Treating Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Women Sexual Disorder Drugs Treating Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Women Sexual Disorder Drugs Treating Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Women Sexual Disorder Drugs Treating Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Pfizer Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 76. Pfizer Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 77. Pfizer Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Teva Pharmaceuticals Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 81. Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 82. Teva Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Teva Pharmaceuticals Main Business
Table 84. Teva Pharmaceuticals Latest Developments
Table 85. Duchesnay Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 86. Duchesnay Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 87. Duchesnay Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Duchesnay Main Business
Table 89. Duchesnay Latest Developments
Table 90. Sprout Pharmaceuticals Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 91. Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 92. Sprout Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Sprout Pharmaceuticals Main Business
Table 94. Sprout Pharmaceuticals Latest Developments
Table 95. Cosette Pharmaceuticals Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 96. Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 97. Cosette Pharmaceuticals Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Cosette Pharmaceuticals Main Business
Table 99. Cosette Pharmaceuticals Latest Developments
Table 100. Lupin Basic Information, Women Sexual Disorder Drugs Treating Manufacturing Base, Sales Area and Its Competitors
Table 101. Lupin Women Sexual Disorder Drugs Treating Product Portfolios and Specifications
Table 102. Lupin Women Sexual Disorder Drugs Treating Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Lupin Main Business
Table 104. Lupin Latest Developments
LIST OF FIGURES
Figure 1. Picture of Women Sexual Disorder Drugs Treating
Figure 2. Women Sexual Disorder Drugs Treating Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Women Sexual Disorder Drugs Treating Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Women Sexual Disorder Drugs Treating Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Women Sexual Disorder Drugs Treating Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Women Sexual Disorder Drugs Treating Sales Market Share by Country/Region (2025)
Figure 10. Women Sexual Disorder Drugs Treating Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Estrogen Therapy
Figure 12. Product Picture of Ospemifene
Figure 13. Product Picture of Flibanserin
Figure 14. Product Picture of Bremelanotide
Figure 15. Product Picture of Others
Figure 16. Global Women Sexual Disorder Drugs Treating Sales Market Share by Type in 2026
Figure 17. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Type (2021-2026)
Figure 18. Women Sexual Disorder Drugs Treating Consumed in Hospital Pharmacies
Figure 19. Global Women Sexual Disorder Drugs Treating Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 20. Women Sexual Disorder Drugs Treating Consumed in Private Clinics
Figure 21. Global Women Sexual Disorder Drugs Treating Market: Private Clinics (2021-2026) & (K Units)
Figure 22. Women Sexual Disorder Drugs Treating Consumed in Retail Pharmacies
Figure 23. Global Women Sexual Disorder Drugs Treating Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 24. Women Sexual Disorder Drugs Treating Consumed in E-Commerce (B2B)
Figure 25. Global Women Sexual Disorder Drugs Treating Market: E-Commerce (B2B) (2021-2026) & (K Units)
Figure 26. Women Sexual Disorder Drugs Treating Consumed in E-Commerce (B2C)
Figure 27. Global Women Sexual Disorder Drugs Treating Market: E-Commerce (B2C) (2021-2026) & (K Units)
Figure 28. Global Women Sexual Disorder Drugs Treating Sale Market Share by Application (2025)
Figure 29. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Application in 2026
Figure 30. Women Sexual Disorder Drugs Treating Sales by Company in 2026 (K Units)
Figure 31. Global Women Sexual Disorder Drugs Treating Sales Market Share by Company in 2026
Figure 32. Women Sexual Disorder Drugs Treating Revenue by Company in 2026 ($ millions)
Figure 33. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Company in 2026
Figure 34. Global Women Sexual Disorder Drugs Treating Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Geographic Region in 2026
Figure 36. Americas Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 37. Americas Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 38. APAC Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 39. APAC Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 40. Europe Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 41. Europe Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 44. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Country in 2026
Figure 45. Americas Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2021-2026)
Figure 46. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 47. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 48. United States Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Region in 2026
Figure 53. APAC Women Sexual Disorder Drugs Treating Revenue Market Share by Region (2021-2026)
Figure 54. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 55. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 56. China Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 60. India Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Women Sexual Disorder Drugs Treating Sales Market Share by Country in 2026
Figure 64. Europe Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2021-2026)
Figure 65. Europe Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 66. Europe Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 67. Germany Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 68. France Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 75. Egypt Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Women Sexual Disorder Drugs Treating in 2026
Figure 81. Manufacturing Process Analysis of Women Sexual Disorder Drugs Treating
Figure 82. Industry Chain Structure of Women Sexual Disorder Drugs Treating
Figure 83. Channels of Distribution
Figure 84. Global Women Sexual Disorder Drugs Treating Sales Market Forecast by Region (2027-2032)
Figure 85. Global Women Sexual Disorder Drugs Treating Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Women Sexual Disorder Drugs Treating Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Women Sexual Disorder Drugs Treating Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Women Sexual Disorder Drugs Treating Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Women Sexual Disorder Drugs Treating Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Women Sexual Disorder Drugs Treating
Figure 2. Women Sexual Disorder Drugs Treating Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Women Sexual Disorder Drugs Treating Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Women Sexual Disorder Drugs Treating Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Women Sexual Disorder Drugs Treating Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Women Sexual Disorder Drugs Treating Sales Market Share by Country/Region (2025)
Figure 10. Women Sexual Disorder Drugs Treating Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Estrogen Therapy
Figure 12. Product Picture of Ospemifene
Figure 13. Product Picture of Flibanserin
Figure 14. Product Picture of Bremelanotide
Figure 15. Product Picture of Others
Figure 16. Global Women Sexual Disorder Drugs Treating Sales Market Share by Type in 2026
Figure 17. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Type (2021-2026)
Figure 18. Women Sexual Disorder Drugs Treating Consumed in Hospital Pharmacies
Figure 19. Global Women Sexual Disorder Drugs Treating Market: Hospital Pharmacies (2021-2026) & (K Units)
Figure 20. Women Sexual Disorder Drugs Treating Consumed in Private Clinics
Figure 21. Global Women Sexual Disorder Drugs Treating Market: Private Clinics (2021-2026) & (K Units)
Figure 22. Women Sexual Disorder Drugs Treating Consumed in Retail Pharmacies
Figure 23. Global Women Sexual Disorder Drugs Treating Market: Retail Pharmacies (2021-2026) & (K Units)
Figure 24. Women Sexual Disorder Drugs Treating Consumed in E-Commerce (B2B)
Figure 25. Global Women Sexual Disorder Drugs Treating Market: E-Commerce (B2B) (2021-2026) & (K Units)
Figure 26. Women Sexual Disorder Drugs Treating Consumed in E-Commerce (B2C)
Figure 27. Global Women Sexual Disorder Drugs Treating Market: E-Commerce (B2C) (2021-2026) & (K Units)
Figure 28. Global Women Sexual Disorder Drugs Treating Sale Market Share by Application (2025)
Figure 29. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Application in 2026
Figure 30. Women Sexual Disorder Drugs Treating Sales by Company in 2026 (K Units)
Figure 31. Global Women Sexual Disorder Drugs Treating Sales Market Share by Company in 2026
Figure 32. Women Sexual Disorder Drugs Treating Revenue by Company in 2026 ($ millions)
Figure 33. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Company in 2026
Figure 34. Global Women Sexual Disorder Drugs Treating Sales Market Share by Geographic Region (2021-2026)
Figure 35. Global Women Sexual Disorder Drugs Treating Revenue Market Share by Geographic Region in 2026
Figure 36. Americas Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 37. Americas Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 38. APAC Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 39. APAC Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 40. Europe Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 41. Europe Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 42. Middle East & Africa Women Sexual Disorder Drugs Treating Sales 2021-2026 (K Units)
Figure 43. Middle East & Africa Women Sexual Disorder Drugs Treating Revenue 2021-2026 ($ millions)
Figure 44. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Country in 2026
Figure 45. Americas Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2021-2026)
Figure 46. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 47. Americas Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 48. United States Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 49. Canada Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 50. Mexico Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 51. Brazil Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 52. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Region in 2026
Figure 53. APAC Women Sexual Disorder Drugs Treating Revenue Market Share by Region (2021-2026)
Figure 54. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 55. APAC Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 56. China Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 57. Japan Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 58. South Korea Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 59. Southeast Asia Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 60. India Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 61. Australia Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 62. China Taiwan Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 63. Europe Women Sexual Disorder Drugs Treating Sales Market Share by Country in 2026
Figure 64. Europe Women Sexual Disorder Drugs Treating Revenue Market Share by Country (2021-2026)
Figure 65. Europe Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 66. Europe Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 67. Germany Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 68. France Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 69. UK Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 70. Italy Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 71. Russia Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 72. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Market Share by Country (2021-2026)
Figure 73. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Market Share by Type (2021-2026)
Figure 74. Middle East & Africa Women Sexual Disorder Drugs Treating Sales Market Share by Application (2021-2026)
Figure 75. Egypt Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 76. South Africa Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 77. Israel Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 78. Turkey Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 79. GCC Countries Women Sexual Disorder Drugs Treating Revenue Growth 2021-2026 ($ millions)
Figure 80. Manufacturing Cost Structure Analysis of Women Sexual Disorder Drugs Treating in 2026
Figure 81. Manufacturing Process Analysis of Women Sexual Disorder Drugs Treating
Figure 82. Industry Chain Structure of Women Sexual Disorder Drugs Treating
Figure 83. Channels of Distribution
Figure 84. Global Women Sexual Disorder Drugs Treating Sales Market Forecast by Region (2027-2032)
Figure 85. Global Women Sexual Disorder Drugs Treating Revenue Market Share Forecast by Region (2027-2032)
Figure 86. Global Women Sexual Disorder Drugs Treating Sales Market Share Forecast by Type (2027-2032)
Figure 87. Global Women Sexual Disorder Drugs Treating Revenue Market Share Forecast by Type (2027-2032)
Figure 88. Global Women Sexual Disorder Drugs Treating Sales Market Share Forecast by Application (2027-2032)
Figure 89. Global Women Sexual Disorder Drugs Treating Revenue Market Share Forecast by Application (2027-2032)
